CDMOP News and Press, Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock From 10/14/21

Leverages Established Track Record of Excellence in Biologics CGMP Manufacturing to Address the Rapidly Growing Cell and Gene Therapy Market World-Class Viral Vector Development and Manufacturing Facility Being Built in Orange County, CA Appoints Drew Brennan, Experience...

TUSTIN, Calif., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology an...

After the recent era of value expansion due to the pandemic and fiscal policy, the use of unbiased rankings may allow for long-term success. As valuations come back down to historical levels, as very few would claim they will stay elevated perpetually, holding the right stocks will be...

Avid Bioservices, Inc. (CDMO) Q1 2022 Earnings Conference Call September 08, 2021, 04:30 PM ET Company Participants Tim Brons - IR Nick Green - President and CEO Dan Hart - CFO Conference Call Participants Sean Dodge - RBC Capital Markets Jacob Johnson - Stephens Matt Hewitt - Craig-Hallum Ca...

-- Recorded First Quarter Revenue of $30.8 Million -- -- Achieved Fifth Consecutive Quarter of Operational Profitability -- --  Signed $23 Million in New Business Orders and Ended the Quarter with a Backlog of $110 Million -- -- Phase 1 and Phase 2 Expansion E...

TUSTIN, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today ...

TUSTIN, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today ...

Healthcare is one market no one can say is going to slow down, and so, many of the best investments lie within. Avid Bioservices aids biotech and pharma companies in the production of CGMP level biologics for commercial therapies. This company has been steadily improving over more...

Laughing Water Capital is a concentrated, long-biased investment partnership open to accredited investors. Laughing Water Capital returned ~9.5% in Q2 2021 after all fees and expenses, vs. 8.6% and 4.3% for the SP500TR and R2000TR respectively. Year to date, LWC has appreciated by ~37...

TUSTIN, Calif., July 01, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pha...